AMPrEP (Amsterdam PrEP)

Phase:Demo Project
Principal Investigator(s):
Objective:To investigate the acceptability, feasibility and usability of an HIV infection prevention program for high-risk MSM through 2 different biomedical intervention strategies at the PHSA: daily Pre-exposure prophylaxis (PrEP) and intermittent Pre-exposure prophylaxis. Focuses on interest in using PrEP, compliance/adherence, risk compensation and cost-benefit analysis. The outcomes of the project will be used to inform the discussion around the inclusion of PrEP as a standard intervention for HIV prevention in the Netherlands.
Prevention Option(s):PrEP
Study Design:
Official Code: AMPrEP (Amsterdam PrEP) (
Trial Sponsors: Academic Medical Center, PHSA
Start Date
End Date
June 12, 2015
December 1, 2018
Age range: 18 Years ↔ any
Population:Cisgender Men, Gay and Bisexual Men Who Have Sex with Men